Pharmacological evaluation of opioid and non-opioid analgesics in a murine bone cancer model of pain
Authors:
- Theo Frans MeertTMTheo Frans Meert
- 1 March 2007
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (3) , 458-467
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic miceEuropean Journal of Pharmacology, 2006
- Cancer-related bone pain is attenuated by a systemically available δ-opioid receptor agonistPain, 2006
- Effects of the local administration of selective μ-, δ-and κ-opioid receptor agonists on osteosarcoma-induced hyperalgesiaNaunyn-Schmiedeberg's Archives of Pharmacology, 2005
- Gabapentin Normalizes Spinal Neuronal Responses That Correlate with Behavior in a Rat Model of Cancer-induced Bone PainAnesthesiology, 2005
- Possible Involvement of Opioidergic and Serotonergic Mechanisms in Antinociceptive Effect of Paroxetine in Acute PainJournal of Pharmacological Sciences, 2004
- Advances in Neuropathic PainArchives of Neurology, 2003
- Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disordersNeuropharmacology, 2002
- Antidepressants and Anticonvulsants for Diabetic Neuropathy and Postherpetic NeuralgiaJournal of Pain and Symptom Management, 2000
- Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer PainJournal of Pain and Symptom Management, 1999
- Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic painNeuroscience Letters, 1996